Can a shot in the eye stop blindness before it starts?
NCT ID NCT02462889
Summary
This study tested whether regular injections of a drug (aflibercept) into the eye could prevent the onset of the severe, vision-damaging form of age-related macular degeneration (AMD) in people at high risk. 128 participants, who had severe AMD in one eye but only early signs in the other, were randomly assigned to receive either the real injection or a sham (pretend) injection every three months for two years. The main goal was to see if the injections could stop the 'good' eye from developing the same leaking blood vessels that cause rapid vision loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NJ Retina
Edison, New Jersey, 08817, United States
-
Ophthalmic Consultants of Boston
Boston, Massachusetts, 02114, United States
-
Retina Consultants of Houston
Houston, Texas, 77030, United States
-
Retina-Vitreous Associates Medical Group
Beverly Hills, California, 90211, United States
Conditions
Explore the condition pages connected to this study.